HIKAL CHEMIC share price has plunged 7% and is presently trading at Rs 337.9.
Meanwhile, the BSE HEALTHCARE index is at 40,635.2 (up 0.3%).
Among the top losers in the BSE HEALTHCARE index today are LAURUS LABS (down 2.6%) and Glenmark Pharma (down 1.8%).
Jubilant Pharmova (up 11.6%) and ASTER DM HEALTHCARE (up 6.3%) are among the top gainers today.
Over the last one year, HIKAL CHEMIC has moved up from Rs 283.8 to Rs 337.9, registering a gain of Rs 54.1 (up 19.1%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,635.2, registering a gain of 46.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 128.9%), SUVEN PHARMACEUTICALS (up 102.2%) and Lupin (up 98.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,867.6 (up 0.2%).
The top gainers among the BSE Sensex today are Power Grid Corp. (up 3.8%) and HDFC Bank (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Power Grid Corp..
In the meantime, NSE Nifty is at 25,006.0 (up 0.2%). Power Grid Corp. and Coal India are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,867.6, registering a gain of 15,339.9 points (up 23.1%).
HIKAL CHEMIC net profit fell 5.6% YoY to Rs 340 million for the quarter ended March 2024, compared to a profit of Rs 360 million a year ago. Net sales declined 5.7% to Rs 5,141 million during the period as against Rs 5,453 million in January-March 2023.
For the year ended March 2023, HIKAL CHEMIC reported 51.2% decrease in net profit to Rs 784 million compared to net profit of Rs 1,605 million during FY22. Revenue of the company grew 4.1% to Rs 20,230 million during FY23.
The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 59.9.
Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Plunges 7%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!